Go to
JCI Insight
About
Editors
Consulting Editors
For authors
Publication ethics
Alerts
Advertising
Job board
Subscribe
Contact
Current issue
Past issues
By specialty
COVID-19
Cardiology
Gastroenterology
Immunology
Metabolism
Nephrology
Neuroscience
Oncology
Pulmonology
Vascular biology
All ...
Videos
Conversations with Giants in Medicine
Author's Takes
Reviews
Reviews
View all reviews ...
Review Series
Lung inflammatory injury and tissue repair (Jul 2023)
Immune Environment in Glioblastoma (Feb 2023)
Korsmeyer Award 25th Anniversary Collection (Jan 2023)
Aging (Jul 2022)
Next-Generation Sequencing in Medicine (Jun 2022)
New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
Immunometabolism (Jan 2022)
View all review series ...
Viewpoint
Collections
In-Press Preview
Commentaries
Research letters
Letters to the editor
Editorials
Viewpoint
Top read articles
Clinical Medicine
JCI This Month
Current issue
Past issues
Mouse model hints at pharmacogenomic strategies for stroke treatment in patients possessing a risk variant
Douglas E. Vaughan
Douglas E. Vaughan
Published September 15, 2023
Citation Information:
J Clin Invest.
2023;
133(18)
:e173932.
https://doi.org/10.1172/JCI173932
.
View:
Text
|
PDF
Editor note
Mouse model hints at pharmacogenomic strategies for stroke treatment in patients possessing a risk variant
Text
PDF
Abstract
Authors
Douglas E. Vaughan
×
Full Text PDF |
Download
(44.90 KB)
